Tumor differentiation--application of prostaglandins in the treatment of neuroblastoma.
Imashuku
S
S
Todo
S
S
Esumi
N
N
Hashida
T
T
Tsunamoto
K
K
Nakajima
F
F
D000008:Abdominal Neoplasms / Q000188:drug therapy; D000527:Alprostadil; D000818:Animals; D001779:Blood Coagulation Factors / Q000096:biosynthesis; D002454:Cell Differentiation / Q000187:drug effects; D002455:Cell Division / Q000187:drug effects; D002478:Cells, Cultured; D002648:Child; D002675:Child, Preschool; D000242:Cyclic AMP / Q000378:metabolism; D004341:Drug Evaluation; D004353:Drug Evaluation, Preclinical; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008297:Male; D051379:Mice; D009447:Neuroblastoma / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D010208:Papaverine / Q000627:therapeutic use; D010972:Platelet Activating Factor; D015230:Prostaglandin D2; D011457:Prostaglandins D / Q000494:pharmacology*; D011458:Prostaglandins E / Q000494:pharmacology / Q000627:therapeutic use*
D001779:Blood Coagulation Factors; D010972:Platelet Activating Factor; D011457:Prostaglandins D; D011458:Prostaglandins E; D010208:Papaverine; D000242:Cyclic AMP; D000527:Alprostadil; D015230:Prostaglandin D2